Clinical Trials Directory

Trials / Completed

CompletedNCT02189473

Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression

Radiotherapy of Motor Deficits From Metastatic Epidural Spinal Cord Compression (10 x 3 Gy Versus 5 x 4 Gy)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
203 (actual)
Sponsor
Prof. Dirk Rades, MD · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this randomized multi-center trial is to investigate the efficacy of the radiotherapy regimens 5 x 4 Gy and 10 x 3 Gy with respect to the effect on motor function in patients with metastatic epidural spinal cord compression.

Detailed description

The primary aim of this randomized multi-center trial is to investigate the efficacy of the radiotherapy regimens 5 x 4 Gy and 10 x 3 Gy with respect to the effect on motor function in patients with metastatic epidural spinal cord compression. The response rate (improvement in motor function or prevention of progression) will be assessed at one month following radiotherapy. In addition, the following endpoints will be evaluated: 1. Motor function; additional assessments directly and at 3 and at 6 months after radiotherapy 2. Ability to walk; assessment directly and at 1, 3 and 6 months after radiotherapy 3. Sensory function; assessment directly and at 1, 3 and 6 months after radiotherapy 4. Quality of life; evaluation directly and at 1, 3 and 6 months after radiotherapy 5. Pain assessment directly and at 1, 3 and 6 months after radiotherapy 6. Overall survival up to 6 months following radiotherapy 7. Local Progression-free survival up to 6 months following radiotherapy

Conditions

Interventions

TypeNameDescription
RADIATIONradiotherapyexternal beam radiotherapy (5 x 4 Gy versus 10 x 3 Gy)

Timeline

Start date
2010-07-01
Primary completion
2015-07-01
Completion
2015-07-01
First posted
2014-07-14
Last updated
2020-03-05
Results posted
2020-02-17

Locations

15 sites across 6 countries: United States, Germany, Lithuania, Saudi Arabia, Slovenia, Spain

Source: ClinicalTrials.gov record NCT02189473. Inclusion in this directory is not an endorsement.